JP6966543B2 - 消化管内微生物組成に影響を及ぼす微生物カロテノイド - Google Patents

消化管内微生物組成に影響を及ぼす微生物カロテノイド Download PDF

Info

Publication number
JP6966543B2
JP6966543B2 JP2019520483A JP2019520483A JP6966543B2 JP 6966543 B2 JP6966543 B2 JP 6966543B2 JP 2019520483 A JP2019520483 A JP 2019520483A JP 2019520483 A JP2019520483 A JP 2019520483A JP 6966543 B2 JP6966543 B2 JP 6966543B2
Authority
JP
Japan
Prior art keywords
gastrointestinal
carotenoids
microbial
intestinal
carotenoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019520483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524877A5 (cg-RX-API-DMAC7.html
JP2019524877A (ja
Inventor
ポッセミエルス，サム
デュイスブルク，シンディー
ピネイロ，イリス
ボルカ，セリン
デン アベーレ，ピーテル ファン
マルツォラッティ，マッシモ
Original Assignee
マイクロバイアル リサーチ マネージメント ヘルス エヌブイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイクロバイアル リサーチ マネージメント ヘルス エヌブイ filed Critical マイクロバイアル リサーチ マネージメント ヘルス エヌブイ
Publication of JP2019524877A publication Critical patent/JP2019524877A/ja
Publication of JP2019524877A5 publication Critical patent/JP2019524877A5/ja
Application granted granted Critical
Publication of JP6966543B2 publication Critical patent/JP6966543B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2019520483A 2016-06-22 2017-06-22 消化管内微生物組成に影響を及ぼす微生物カロテノイド Active JP6966543B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16175832.1 2016-06-22
EP16175832 2016-06-22
PCT/EP2017/065348 WO2017220708A1 (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Publications (3)

Publication Number Publication Date
JP2019524877A JP2019524877A (ja) 2019-09-05
JP2019524877A5 JP2019524877A5 (cg-RX-API-DMAC7.html) 2020-07-27
JP6966543B2 true JP6966543B2 (ja) 2021-11-17

Family

ID=56203217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019520483A Active JP6966543B2 (ja) 2016-06-22 2017-06-22 消化管内微生物組成に影響を及ぼす微生物カロテノイド

Country Status (12)

Country Link
US (1) US11324717B2 (cg-RX-API-DMAC7.html)
EP (1) EP3474862B1 (cg-RX-API-DMAC7.html)
JP (1) JP6966543B2 (cg-RX-API-DMAC7.html)
KR (1) KR102413408B1 (cg-RX-API-DMAC7.html)
CN (1) CN109641006B (cg-RX-API-DMAC7.html)
AU (1) AU2017281589B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018076485A8 (cg-RX-API-DMAC7.html)
CA (1) CA3028031C (cg-RX-API-DMAC7.html)
IL (1) IL263683B (cg-RX-API-DMAC7.html)
MX (1) MX390386B (cg-RX-API-DMAC7.html)
RU (1) RU2759600C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017220708A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10220089B2 (en) 2012-08-29 2019-03-05 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
AU2015339284B2 (en) 2014-10-30 2021-08-05 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
WO2018148220A1 (en) * 2017-02-07 2018-08-16 California Institute Of Technology Modulation of gut microbiota in huntington's disease and rett syndrome
EP3720458A4 (en) 2017-12-05 2021-12-08 BioPlx, Inc. METHODS AND COMPOSITIONS FOR PREVENTING MICROBIAL INFECTION
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
KR102369996B1 (ko) * 2020-04-21 2022-03-02 박선민 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用
CN119184223A (zh) * 2024-10-14 2024-12-27 元医(杭州)科技有限公司 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
GB0524873D0 (en) * 2005-12-06 2006-01-11 New Royal Holloway & Bedford Bacterial production of carotenoids
GB201013041D0 (en) * 2010-08-03 2010-09-15 Royal Holloway & New Bedford College Carotenoids

Also Published As

Publication number Publication date
RU2019101481A (ru) 2020-07-22
CA3028031C (en) 2023-02-28
AU2017281589B2 (en) 2023-03-23
US20190209516A1 (en) 2019-07-11
KR102413408B1 (ko) 2022-06-27
CA3028031A1 (en) 2017-12-28
BR112018076485A2 (pt) 2019-04-09
IL263683A (en) 2019-01-31
EP3474862B1 (en) 2025-10-29
BR112018076485A8 (pt) 2022-12-06
KR20190039687A (ko) 2019-04-15
CN109641006B (zh) 2022-07-01
RU2019101481A3 (cg-RX-API-DMAC7.html) 2020-10-16
MX390386B (es) 2025-03-20
RU2759600C2 (ru) 2021-11-16
CN109641006A (zh) 2019-04-16
US11324717B2 (en) 2022-05-10
JP2019524877A (ja) 2019-09-05
AU2017281589A1 (en) 2019-01-31
MX2018016118A (es) 2019-07-08
WO2017220708A1 (en) 2017-12-28
EP3474862A1 (en) 2019-05-01
IL263683B (en) 2022-04-01

Similar Documents

Publication Publication Date Title
JP6966543B2 (ja) 消化管内微生物組成に影響を及ぼす微生物カロテノイド
Leonard et al. Hydroxycinnamic acids on gut microbiota and health
Shang et al. In vitro and in vivo antioxidant activities of inulin
Bomba et al. Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids
JP6608047B2 (ja) 多様な機能性を有する新規乳酸菌およびその用途
JP6954563B2 (ja) 代謝障害を処置するための低温殺菌アッカーマンシアの使用
Yang et al. Effects of probiotic, Clostridium butyricum, on growth performance, immune function, and cecal microflora in broiler chickens
CN102548566B (zh) 植物乳杆菌菌株用作降血胆固醇试剂
Tlaskalova-Hogenova et al. Microbiome and colorectal carcinoma: insights from germ-free and conventional animal models
Dias et al. Effects of lycopene, synbiotic and their association on early biomarkers of rat colon carcinogenesis
Delgado et al. The putative effects of prebiotics as immunomodulatory agents
Abbasi et al. Postbiotics: science, technology and applications
BR112018009192B1 (pt) Uso de uma composição fermentada de um material vegetal fornecida por um processo essencialmente homofermentativo e produto de combinação compreendendo a referida composição
JP2019524138A (ja) ラクトバチルス・アシドフィルスを含む更年期の予防または治療用組成物
Wang et al. The effects of dietary ellagic acid supplementation on growth performance, immune response, antioxidant activity, digestive enzyme activities, and intestinal functions in yellow-feathered broilers
Odun-Ayo et al. The effect of modified citrus pectin-probiotic on faecal lactobacilli in Balb/c mice
Mateova et al. Effect of probiotics, prebiotics and herb oil on performance and metabolic parameters of broiler chickens
Stevens et al. Effect of a carotenoid-producing Bacillus strain on intestinal barrier integrity and systemic delivery of carotenoids: A randomised trial in animals and humans
US20230065964A1 (en) Composition for enhancing urolithin production in a human subject
Bakheet et al. Intestinal anti-inflammatory improvement with fenugreek seeds as a prebiotic and synbiotic with Lactobacillus acidophilus in rats experimentally infected with Escherichia coli
Wu et al. Modulating microbiota as a new strategy for breast cancer prevention and treatment. Microorganisms. 2022; 10: 1727
Rostampour et al. The effect of Froriepia subpinnata on the performance, carcass characteristics, blood parameters, immune system, microbial population, intestinal morphology, and breast meat fatty acid content of broiler chickens
US20190307802A1 (en) Probiotic compositions including immune modulators
FR3114106A1 (fr) Souche bactérienne appartenant au genre Christensenella et compositions
JP7681851B2 (ja) リン脂質ヒドロペルオキシド依存性細胞死が関連する疾患の予防又は治療用医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200615

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210614

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210714

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20210805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20210805

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210929

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211021

R150 Certificate of patent or registration of utility model

Ref document number: 6966543

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250